USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/10012
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbass, Alavi
dc.date.accessioned2020-05-28T19:34:30Z
dc.date.available2020-05-28T19:34:30Z
dc.date.issued2018
dc.identifier.citationABASS, Alavi. What can and what cannot be accomplished with PET: clarifying ongoing misconceptions. In: The Moldovan Medical Journal. 2018, vol. 61, RMI Congress Issue, p. 41. ISSN 2537-6381.
dc.identifier.issn2537-6373
dc.identifier.issn2537-6381
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2018/05/The-Moldovan-Medical-Journal-vol-61-mai.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/10012
dc.descriptionDepartment of Radiology, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA, The IVth Congress of Radiology and Medical Imaging of the Republic of Moldova with international participation, Chisinau, May 31 – June 2, 2018en_US
dc.description.abstractBackground: The introduction of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in 1976 as a joint effort of the University of Pennsylvania and Brookhaven National Laboratory opened new perspectives in medical imaging. Although FDG PET/CT has become a unique cornerstone of molecular imaging and one of the most widely used imaging modalities, familiarity with its limitations is of paramount importance for avoiding unnecessary examinations. Content: FDG PET and PET/CT are now widely used in many oncologic diseases for tumor staging/re-staging and monitoring of disease activity as well as for evaluating the response to administered therapy. However, FDG is a nonspecific tracer and can also accumulate at the sites of many benign processes. Even though dual time-point imaging of FDG PET may be helpful in differentiating malignant from benign processes, exceptions exist, and some authors have even demonstrated significant overlap of FDG uptake patterns in malignant and benign lesions. A variety of other PET radiopharmaceuticals such as FLT, 60Cu-ATSM, 18F-EF5, 18F-FMISO, FIAU, FHBG, FHPG, 11C-Acetate, 18F-Fuoride, 94mTc-MIBI, 18F or 11C -labeled Choline are increasingly being used in various disorders and their area of clinical applications is expanding. In this context, the lecture is also approaching various controversial domains such as PET applications for imaging islets in pancreas, detecting plaques and tangles in Alzheimer’s disease or bacteria at sites of infection. Last, but not least, the presentation provides a brief summary related to novel quantitative techniques such as partial volume correction and global disease assessment. Conclusion: At the end of the lecture attendees would expand their knowledge about what can and what cannot be accomplished with FDG PET/CT imaging.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journal: The IVth Congress of Radiology and Medical Imaging of the Republic of Moldova with international participation, Chisinau, May 31 – June 2, 2018
dc.subjectPositron emission tomographyen_US
dc.subjectFluorodeoxyglucoseen_US
dc.subjectFDG PET/CT limitationsen_US
dc.subject.meshPositron-emission tomography - methodsen_US
dc.subject.meshFluorodeoxyglucose F18en_US
dc.subject.meshPositron emission tomography computed tomography - methodsen_US
dc.titleWhat can and what cannot be accomplished with PET: clarifying ongoing misconceptionsen_US
dc.typeArticleen_US
Appears in Collections:The Moldovan Medical Journal, Vol. 61, May 2018 RMI Congress Issue

Files in This Item:
File Description SizeFormat 
What_can_and_what_cannot_be_accomplished_with_PET.pdf55.87 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback